Registered entities
Immune-Onc Therapeutics, Inc.
Reg. No. 81-2180798United States
Innovation
7 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 395 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Social engagement
Social engagement: 4K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
21 investors on record; lead investors include Oceanpine Capital, NLVC, Vivo Capital, Triwise Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 43% |
| Private equity | 5 | 24% |
| Accelerator & incubator | 1 | 5% |
| Other / undisclosed | 6 | 29% |
Recent activity
18 Jul 2025
Event
Life Science panel